Otorhinolaryngology Devices Market by Product Type (Diagnostic Devices, Surgical Devices, Hearing Aids, Image Guided Surgery Systems, and Others) and End User (Hospitals, ENT Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

February 2020 | 207 pages | ID: O570F17C5E5EEN
Allied Market Research

Abstracts

The global otorhinolaryngology devices market was valued at $9,268 million in 2018, and is projected to reach $13,999 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.Otorhinolaryngology devices are used to treat and diagnose disorders related to ear, nose, and throat, such as smelling disorders, hearing disorders as well as problems associated with speaking or snoring. It includes several diagnostics and surgical products such as endoscopes, powered surgical instruments, handheld surgical instruments, balloon sinus dilation devices, hearing screening devices, hearing aids, hearing implants, CO2 lasers, image-guided surgery systems, ear tubes, nasal and otological devices. These otorhinolaryngology devices assist otolaryngologists for the treatment of patients suffering from disorders of ear, nose, throat, and related structures of the head & neck.

The global otorhinolaryngologydevices market is anticipated to experience significant growth during the forecast period due to technological advancements and rise in prevalence rate of diseases that require otorhinolaryngology devices. In addition, favorable FDA approvals & reimbursement policies in developed economies, surge in patient preference for minimally invasive surgeries, and shorter recovery time & minimal postoperative complications further drive the growth of the global otorhinolaryngology devices market. However, high cost of otorhinolaryngology instruments and procedure and stringent government regulations hinder the growth of the market globally. On the contrary, various growth opportunities from emerging economies are anticipated to provide lucrative opportunities for the otorhinolaryngology devices market growth.

The global otorhinolaryngology devices market is segmented on the basis of product, end user, and region. By product, the market is bifurcated into diagnostic devices, surgical devices, hearing aids, image-guided surgery systems, and others. By end user, the market is segmented into hospitals, ENT clinics, and others. Regionwise, the otorhinolaryngology devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY MARKET BENEFITS

• This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2026, which assist to identify the prevailing market opportunities.
• An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
• A comprehensive analysis of the factors that drive and restrain the growth of the global otorhinolaryngology devicesmarket is provided.
• An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

• By Product
• Diagnostic Devices
• Surgical Devices
• Hearing Aids
• Image-guided Surgery Systems
• Others
• By End User
• Hospitals
• ENT Clinics
• Others
• By Region
• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• Spain
• Italy
• UK
• Rest of Europe
• Asia-Pacific
• Australia
• Japan
• India
• China
• South Korea
• Rest of Asia-Pacific
• LAMEA
• Brazil
• Saudi Arabia
• South Africa
• Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Atos Medical AB
• Cochlear Ltd.
• Freudenberg SE (InHealth Technologies, Inc.)
• Hill-Rom Holdings, Inc.
• Johnson & Johnson (Acclarent, Inc.)
• Medtronic Plc.
• Olympus Corporation
• Sonova Group
• Starkey Hearing Technologies
• Stryker Corporation

The other players in the value chain (profiles not included in the report)

• Smith & Nephew plc
• Hoya Corporation
• William Demant Holdings A/S
• Stema Medizin
• Siemens Healthcare

Contents

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
  1.4.1. Secondary research
  1.4.2. Primary research
  1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings
  3.2.1. Top investment pockets
3.3. Porter's five force analysis
3.4. Market dynamics
  3.4.1. Drivers
    3.4.1.1. High prevalence of chronic sinusitis
    3.4.1.2. Rise in adoption of minimally invasive ENT procedures
    3.4.1.3. Rapid growth in the elderly population
  3.4.2. Restraints
    3.4.2.1. Limited awareness and high costs
    3.4.2.2. Government regulations and reimbursement issues
  3.4.3. Opportunity
    3.4.3.1. High growth prospects in emerging markets

CHAPTER 4: OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT

4.1. Overview
  4.1.1. Market size and forecast
4.2. Diagnostic Devices
  4.2.1. Key market trends, growth factors, and opportunities
  4.2.2. Market size and forecast, by region
  4.2.3. Market analysis, by country
4.3. Surgical Devices
  4.3.1. Key market trends, growth factors, and opportunities
  4.3.2. Market size and forecast, by region
  4.3.3. Market analysis, by country
4.4. Hearing Aids
  4.4.1. Key market trends, growth factors, and opportunities
  4.4.2. Market size and forecast, by region
  4.4.3. Market analysis, by country
4.5. Image-guided Surgery Systems
  4.5.1. Key market trends, growth factors, and opportunities
  4.5.2. Market size and forecast, by region
  4.5.3. Market analysis, by country
4.6. Others
  4.6.1. Key market trends, growth factors, and opportunities
  4.6.2. Market size and forecast, by region
  4.6.3. Market analysis, by country

CHAPTER 5: GLOBAL OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER

5.1. Overview
  5.1.1. Market size and forecast
5.2. Hospitals
  5.2.1. Market size and forecast, by region
  5.2.2. Market analysis, by country
5.3. ENT Clinics
  5.3.1. Market size and forecast, by region
  5.3.2. Market analysis, by country
5.4. Others
  5.4.1. Market size and forecast, by region
  5.4.2. Market analysis, by country

CHAPTER 6: OTORHINOLARYNGOLOGY DEVICES CAMERA MARKET, BY REGION

6.1. OVERVIEW
  6.1.1. Market size and forecast
6.2. North America
  6.2.1. Key market trends and opportunities
  6.2.2. North America otorhinolaryngology devices market, by country
    6.2.2.1. U.S. otorhinolaryngology devices market, by product
    6.2.2.2. U.S. otorhinolaryngology devices market, by end user
    6.2.2.3. Canada otorhinolaryngology devices market, by product
    6.2.2.4. Canada otorhinolaryngology devices market, by end user
    6.2.2.5. Mexico otorhinolaryngology devices market, by product
    6.2.2.6. Mexico otorhinolaryngology devices market, by end user
  6.2.3. North America otorhinolaryngology devices market, by product
  6.2.4. North America otorhinolaryngology devices market, by end user
6.3. Europe
  6.3.1. Key market trends and opportunities
  6.3.2. Europe otorhinolaryngology devices market, by country
    6.3.2.1. Germany otorhinolaryngology devices market, by product
    6.3.2.2. Germany otorhinolaryngology devices market, by end user
    6.3.2.3. France otorhinolaryngology devices market, by product
    6.3.2.4. France otorhinolaryngology devices market, by end user
    6.3.2.5. UK otorhinolaryngology devices market, by product
    6.3.2.6. UK otorhinolaryngology devices market, by end user
    6.3.2.7. Italy otorhinolaryngology devices market, by product
    6.3.2.8. Italy otorhinolaryngology devices market, by end user
    6.3.2.9. Spain otorhinolaryngology devices market, by product
    6.3.2.10. Spain otorhinolaryngology devices market, by end user
    6.3.2.11. Rest of Europe otorhinolaryngology devices market, by product
    6.3.2.12. Rest of Europe otorhinolaryngology devices market, by end user
  6.3.3. Europe otorhinolaryngology devices market, by product
  6.3.4. Europe otorhinolaryngology devices market, by end user
6.4. Asia-Pacific
  6.4.1. Key market trends and opportunities
  6.4.2. Asia-Pacific otorhinolaryngology devices market, by country
    6.4.2.1. Japan otorhinolaryngology devices market, by product
    6.4.2.2. Japan otorhinolaryngology devices market, by end user
    6.4.2.3. China otorhinolaryngology devices market, by product
    6.4.2.4. China otorhinolaryngology devices market, by end user
    6.4.2.5. Australia otorhinolaryngology devices market, by product
    6.4.2.6. Australia otorhinolaryngology devices market, by end user
    6.4.2.7. India otorhinolaryngology devices market, by product
    6.4.2.8. India otorhinolaryngology devices market, by end user
    6.4.2.9. South Korea otorhinolaryngology devices market, by product
    6.4.2.10. South Korea otorhinolaryngology devices market, by end user
    6.4.2.11. Rest of Asia-Pacific otorhinolaryngology devices market, by product
    6.4.2.12. Rest of Asia-Pacific otorhinolaryngology devices market, by end user
  6.4.3. Asia-Pacific otorhinolaryngology devices market, by product
  6.4.4. Asia-Pacific otorhinolaryngology devices market, by end user
6.5. LAMEA
  6.5.1. Key market trends and opportunities
  6.5.2. LAMEA otorhinolaryngology devices market, by country
    6.5.2.1. Brazil otorhinolaryngology devices market, by product
    6.5.2.2. Brazil otorhinolaryngology devices market, by end user
    6.5.2.3. Saudi Arabia otorhinolaryngology devices market, by product
    6.5.2.4. Saudi Arabia otorhinolaryngology devices market, by end user
    6.5.2.5. South Africa otorhinolaryngology devices market, by product
    6.5.2.6. South Africa otorhinolaryngology devices market, by end user
    6.5.2.7. Rest of LAMEA otorhinolaryngology devices market, by product
    6.5.2.8. Rest of LAMEA otorhinolaryngology devices market, by end user
  6.5.3. LAMEA otorhinolaryngology devices market, by product
  6.5.4. LAMEA otorhinolaryngology devices market, by end user

CHAPTER 7: COMPANY PROFILES

7.1. Atos Medical AB
  7.1.1. Company overview
  7.1.2. Company snapshot
  7.1.3. Operating business segments
  7.1.4. Product portfolio
  7.1.5. Business performance
7.2. Cochlear Ltd.
  7.2.1. Company overview
  7.2.2. Company snapshot
  7.2.3. Operating business segments
  7.2.4. Product Portfolio
  7.2.5. Business performance
  7.2.6. Key strategic moves and developments
7.3. Freudenberg SE (InHealth Technologies, Inc.)
  7.3.1. Company overview
  7.3.2. Company snapshot
  7.3.3. Operating business segments
  7.3.4. Product portfolio
  7.3.5. Business performance
  7.3.6. Key strategic moves and developments
7.4. HILL-ROM HOLDINGS, INC.
  7.4.1. Company overview
  7.4.2. Company snapshot
  7.4.3. Operating business segments
  7.4.4. Product Portfolio
  7.4.5. Business performance
  7.4.6. Key strategic moves and developments
7.5. Johnson & Johnson (Acclarent, Inc.)
  7.5.1. Company overview
  7.5.2. Company snapshot
  7.5.3. Operating business segments
  7.5.4. Product portfolio
  7.5.5. Business performance
  7.5.6. Key strategic moves and developments
7.6. Medtronic Plc.
  7.6.1. Company overview
  7.6.2. Company snapshot
  7.6.3. Operating business segments
  7.6.4. Product portfolio
  7.6.5. Business performance
7.7. Olympus Corporation
  7.7.1. Company overview
  7.7.2. Company snapshot
  7.7.3. Operating business segments
  7.7.4. Product portfolio
  7.7.5. Business performance
  7.7.6. Key strategic moves and developments
7.8. Sonova Group
  7.8.1. Company overview
  7.8.2. Company snapshot
  7.8.3. Operating business segments
  7.8.4. Product portfolio
  7.8.5. Business performance
  7.8.6. Key strategic moves and developments
7.9. Starkey Hearing Technologies
  7.9.1. Company overview
  7.9.2. Company snapshot
  7.9.3. Operating business segments
  7.9.4. Product portfolio
  7.9.5. Business performance
  7.9.6. Key strategic moves and developments
7.10. Stryker Corporation
  7.10.1. Company overview
  7.10.2. Company snapshot
  7.10.3. Operating business segments
  7.10.4. Product portfolio
  7.10.5. Business performance
  7.10.6. Key strategic moves and developments

List Of Tables

LIST OF TABLES

TABLE 01. OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 02. OTORHINOLARYNGOLOGY DEVICES MARKET FOR DIAGNOSTIC DEVICES, BY REGION 2018–2026 ($MILLION)
TABLE 03. OTORHINOLARYNGOLOGY DEVICES MARKET FOR SURGICAL DEVICES, BY REGION 2018–2026 ($MILLION)
TABLE 04. OTORHINOLARYNGOLOGY DEVICES MARKET FOR HEARING AIDS, BY REGION 2018–2026 ($MILLION)
TABLE 05. OTORHINOLARYNGOLOGY DEVICES MARKET FOR IMAGE-GUIDED SURGERY SYSTEMS, BY REGION 2018–2026 ($MILLION)
TABLE 06. OTORHINOLARYNGOLOGY DEVICES MARKET FOR OTHER PRODUCTS, BY REGION 2018–2026 ($MILLION)
TABLE 07. OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 08. OTORHINOLARYNGOLOGY DEVICES MARKET FOR HOSPITALS, BY REGION 2018–2026 ($MILLION)
TABLE 09. OTORHINOLARYNGOLOGY DEVICES MARKET FOR ENT CLINICS, BY REGION 2018–2026 ($MILLION)
TABLE 10. OTORHINOLARYNGOLOGY DEVICES MARKET FOR OTHER END USER, BY REGION 2018–2026 ($MILLION)
TABLE 11. OTORHINOLARYNGOLOGY DEVICES MARKET REVENUE, BY REGION, 2018–2026 ($MILLION)
TABLE 12. NORTH AMERICA OTORHINOLARYNGOLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 13. U.S. OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 14. U.S. OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 15. CANADA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 16. CANADA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 17. MEXICO OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 18. MEXICO OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 19. NORTH AMERICA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 20. NORTH AMERICA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 21. EUROPE OTORHINOLARYNGOLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 22. GERMANY OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 23. GERMANY OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 24. FRANCE OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 25. FRANCE OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 26. UK OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 27. UK OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 28. ITALY OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 29. ITALY OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 30. SPAIN OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 31. SPAIN OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 32. REST OF EUROPE OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 33. REST OF EUROPE OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 34. EUROPE OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 35. EUROPE OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 36. ASIA-PACIFIC OTORHINOLARYNGOLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 37. JAPAN OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 38. JAPAN OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 39. CHINA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 40. CHINA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 41. AUSTRALIA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 42. AUSTRALIA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 43. INDIA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 44. INDIA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 45. SOUTH KOREA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 46. SOUTH KOREA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 47. REST OF ASIA-PACIFIC OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 48. REST OF ASIA-PACIFIC OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 49. ASIA-PACIFIC OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 50. ASIA-PACIFIC OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 51. LAMEA OTORHINOLARYNGOLOGY DEVICES MARKET, BY COUNTRY, 2018–2026 ($MILLION)
TABLE 52. BRAZIL OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 53. BRAZIL OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 54. SAUDI ARABIA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 55. SAUDI ARABIA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 56. SOUTH AFRICA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 57. SOUTH AFRICA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 58. REST OF LAMEA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 59. REST OF LAMEA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 60. LAMEA OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT, 2018–2026 ($MILLION)
TABLE 61. LAMEA OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER, 2018–2026 ($MILLION)
TABLE 62. ATOS: COMPANY SNAPSHOT
TABLE 63. ATOS: OPERATING SEGMENTS
TABLE 64. ATOS: PRODUCT PORTFOLIO
TABLE 65. COCHLEAR: COMPANY SNAPSHOT
TABLE 66. COCHLEAR: OPERATING SEGMENTS
TABLE 67. COCHLEAR: PRODUCT PORTFOLIO
TABLE 68. FREUDENBERG: SNAPSHOT
TABLE 69. FREUDENBERG: OPERATING SEGMENTS
TABLE 70. FREUDENBERG: PRODUCT PORTFOLIO
TABLE 71. HILL-ROM: COMPANY SNAPSHOT
TABLE 72. HILL-ROM: BUSINESS UNITS
TABLE 73. J&J: COMPANY SNAPSHOT
TABLE 74. J&J: OPERATING SEGMENTS
TABLE 75. J&J: PRODUCT PORTFOLIO
TABLE 76. MEDTRONIC: COMPANY SNAPSHOT
TABLE 77. MEDTRONIC: OPERATING SEGMENTS
TABLE 78. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 79. OLYMPUS: COMPANY SNAPSHOT
TABLE 80. OLYMPUS: OPERATING SEGMENTS
TABLE 81. OLYMPUS: PRODUCT PORTFOLIO
TABLE 82. SONOVA: COMPANY SNAPSHOT
TABLE 83. SONOVA: OPERATING SEGMENTS
TABLE 84. SONOVA: PRODUCT PORTFOLIO
TABLE 85. STARKEY: COMPANY SNAPSHOT
TABLE 86. STARKEY: PRODUCT PORTFOLIO
TABLE 87. STRYKER: COMPANY SNAPSHOT
TABLE 88. STRYKER: OPERATING SEGMENTS
TABLE 89. STRYKER: PRODUCT PORTFOLIO

List Of Figures

LIST OF FIGURES

FIGURE 01. TOP INVESTMENT POCKETS
FIGURE 02. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 03. HIGH BARGAINING POWER OF BUYERS
FIGURE 04. MODERATE THREAT OF NEW ENTRANTS
FIGURE 05. LOW THREAT OF SUBSTITUTION
FIGURE 06. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 07. TOP IMPACTING FACTORS
FIGURE 08. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES CAMERAS FOR DIAGNOSTIC DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES MARKET FOR SURGICAL DEVICES, BY COUNTRY, 2018 & 2026 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES MARKET FOR HEARING AIDS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES MARKET FOR IMAGE-GUIDED SURGERY SYSTEMS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES MARKET FOR ENT CLINICS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF OTORHINOLARYNGOLOGY DEVICES MARKET FOR OTHER END USER, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16. ATOS: NET SALES, 2016–2018 ($MILLION)
FIGURE 17. ATOS: NET SALES BY DIVISION, 2018 (%)
FIGURE 18. ATOS: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 19. NET SALES, 2016–2018 ($MILLION)
FIGURE 20. COCHLEAR: NET SALES BY DIVISION, 2018 (%)
FIGURE 21. COCHLEAR: NET SALES BY REGION, 2018 (%)
FIGURE 22. FREUDENBERG: NET SALES, 2016–2018 ($MILLION)
FIGURE 23. FREUDENBERG: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 24. FREUDENBERG REVENUE SHARE BY REGION, 2018 (%)
FIGURE 25. NET SALES, 2016–2018 ($MILLION)
FIGURE 26. HILL-ROM: REVENUE SHARE BY BUSINESS UNIT, 2018 (%)
FIGURE 27. HILL-ROM: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 28. J&J: REVENUE, 2016–2018 ($MILLION)
FIGURE 29. J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 30. J&J: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 31. MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 32. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33. MEDTRONIC: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34. OLYMPUS: NET SALES, 2016–2018 ($MILLION)
FIGURE 35. OLYMPUS: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 36. OLYMPUS: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 37. SONOVA: NET SALES, 2016–2018 ($MILLION)
FIGURE 38. SONOVA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 39. SONOVA: REVENUE SHARE BY REGION, 2018(%)
FIGURE 40. STRYKER: NET SALES, 2016–2018 ($MILLION)
FIGURE 41. STRYKER: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 42. STRYKER: REVENUE SHARE BY REGION, 2018 (%)